MannKind | L'Utile Operativo



Operating Profit Cambiamento Data
Adma Biologics USD 37.08M 2.56M 2024-12
Dynavax Technologies USD -23630000 22M 2025-03
Eli Lilly USD 5.41B 259.6M 2025-03
Halozyme Therapeutics USD 141.54M 33.97M 2025-03
Insmed USD -248140000 17.73M 2025-03
MacroGenics USD -16587000 70.78M 2024-12
MannKind USD 22.29M 9.19M 2025-03
Merck USD 6.36B 494M 2025-06
Novo Nordisk DKK 38.79B 4.97B 2025-03
Pfizer USD 3.67B 4.08B 2025-03
Sanofi EUR 1.71B 573M 2025-06
Xencor USD -43183000 47.23M 2025-03


MannKind L'Utile Operativo - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Aug 2025.